Micro Sugar APP+ Medtronic Insulin Pump: Creating a New Mode of Diabetes Management

Micro Sugar APP+ Medtronic Insulin Pump: Creating a New Mode of Diabetes Management

The micro-sugar start-up team was founded in 2013, formerly known as Bo Medical, and changed its name to Micro-Sugar in 2014. Micro-sugar is a platform for chronic disease management services for diabetic patients and senior sugar friends. At the same time, micro-sugar also provides a patient management platform for doctors, nutritionists, nurses and other people. At present, the platform of micro-sugar has signed 11,000 diabetes specialists nationwide, with more than 2 million registered users.

The number of diabetic patients is huge, and traditional syringes can no longer meet the needs of regulating blood sugar.

On April 6, 2016, the World Health Organization released the Global Diabetes Report for the first time. According to the report, among the population over 18 years old, there were 108 million people with diabetes in 1980. In 2014, it increased to 422 million people, accounting for the total population of the year. 8.5%. Diabetes can be divided into type 1 (insulin-dependent), type 2 (adult-onset) and gestational diabetes. The report states that the incidence of type 2 diabetes in China has grown rapidly in the past few decades. In 1980, China The male population with diabetes accounts for about 5%, and currently this proportion exceeds 10%.

Among all adult adults in China, the number of people with diabetes accounts for 10%, of which the male prevalence rate is 10.5% and the female prevalence rate is 8.3%. Diabetes has a major impact on human health and the socio-economics. Every year, the cost of treating diabetes worldwide exceeds $827 billion. Complications of diabetes can lead to cardiovascular disease, renal failure, blindness, amputation, etc., causing more inconvenience to patients' lives.

Micro Sugar APP+ Medtronic Insulin Pump: Creating a New Mode of Diabetes Management

Statistics and prediction table for patients with diabetes in China

Currently, the management tools for diabetes are diet control, self-test blood glucose and insulin therapy. When intensive treatment is performed in patients with type 1 diabetes, 4 pre-prandial blood glucose levels need to be monitored every day, and 8 times when blood glucose levels are unstable. Moreover, in the course of insulin therapy, non-intensive treatments require 2-3 injections per day, and intensive treatments require 3-4 injections per day. At present, the widely used injection method is a traditional syringe. The traditional injection method is simple, quick and easy to grasp. The patient can perform independent operation, but the patient cannot reasonably control the amount of insulin that needs to be injected every day, and it is prone to excessive injection to cause hypoglycemia. Case.

Micro Sugar APP+ Medtronic Insulin Pump: Creating a New Mode of Diabetes Management

Comparison of insulin pump therapy and non-insulin pump therapy for severe hypoglycemia

Biological Product For Human

Tetanus Toxoid Vaccine,Toxoid Vaccine,Hep B Immune Globulin,Immunoglobulin Injections

FOSHAN PHARMA CO., LTD. , https://www.full-pharma.com